Publication
Utility of artificial intelligence for identifying thoracic lymphadenopathy in lung cancer.
Muhiddin Dervis, Anushree Burade, Michael Lanuti, Ibiayi Dagogo-Jack, Subba R Digumarthy
Lung cancer (Amsterdam, Netherlands)Oct 1, 2026PMID 42673682doi:10.1016/j.lungcan.2026.109596 Journal ArticleMulticenter StudypubmedProvenance
- Source
- PubMed
- Retrieved
- Sep 19, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-PUBMED-20260919-000001
Abstract
Abstract (excerpt)
Only the opening of the abstract is shown; abstract text may carry publisher copyright.
PURPOSE: To evaluate the performance of an artificial intelligence (AI) system for detecting, classifying, and measuring AI-detected thoracic lymph node candidates on CT and compare AI detection with routine radiology reporting and histopathologic findings. METHODS: In this HIPAA-compliant,…
Read on PubMedLinked entities
Linked entities (1)
How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.
Candidate 1
- cancerMalignant Lung Neoplasmdictionary0.60
Curated evidence
Evidence citing this paper (0)
Data not yet available
No curated evidence item cites this publication.